$18.8 Million is the total value of Hillview Capital Advisors, LLC's 6 reported holdings in Q1 2019. The portfolio turnover from Q4 2018 to Q1 2019 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| INNT | INNOVATE BIOPHARMACEUTICLS I | $38,000 | -15.6% | 19,610 | 0.0% | 0.20% | -25.5% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-05-13
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VANGUARD INTL EQUITY INDEX F | 19 | Q2 2019 | 92.7% |
| TORTOISE ENERGY INFRSTRCTR C | 12 | Q3 2017 | 38.5% |
| VANGUARD TAX MANAGED INTL FD | 10 | Q2 2019 | 76.4% |
| VANGUARD INDEX FDS | 9 | Q2 2018 | 2.8% |
| SPDR S&P 500 ETF TR | 8 | Q4 2017 | 4.2% |
| WISDOMTREE TR | 7 | Q2 2016 | 6.1% |
| KAYNE ANDERSON MLP INVT CO | 5 | Q4 2015 | 61.0% |
| WISDOMTREE TR | 4 | Q2 2016 | 6.5% |
| INNOVATE BIOPHARMACEUTICLS I | 4 | Q2 2019 | 0.5% |
| OPHTHOTECH CORP | 3 | Q2 2015 | 3.1% |
View Hillview Capital Advisors, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2019-08-01 |
| 13F-HR | 2019-05-13 |
| 13F-HR | 2019-02-01 |
| 13F-HR | 2018-10-23 |
| 13F-HR | 2018-07-25 |
| 13F-HR | 2018-04-30 |
| 13F-HR | 2018-02-02 |
| 13F-HR | 2017-11-13 |
| 13F-HR | 2017-07-27 |
| 13F-HR | 2017-05-15 |
View Hillview Capital Advisors, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.